HB
Hecht Beth
Executive
OtherF
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Hecht Beth, Executive. Insider active across 3 companies, notably Xeris Biopharma Holdings, Inc.. In total, 20 filings have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €890k. Activity tracked since 3 January 2022. The latest transaction was filed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hecht Beth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
16,666 shares@ US$8.01350.0058% mcap10.0% of flowCommon StockSEC:0001652410-26-000016:0
16,667 shares@ US$6.22820.0044% mcap15.2% of flowCommon StockSEC:0001652410-26-000010:0
16,667 shares@ US$5.991412.9% of flowCommon StockSEC:0001652410-26-000008:0
16,567 shares@ US$6.24018.2% of flowCommon StockSEC:0001652410-26-000006:0
121,293 shares0Common StockSEC:0001652410-26-000004:0
16,667 shares@ US$7.42649.8% of flowCommon StockSEC:0001652410-26-000002:0
16,667 shares@ US$7.006711.5% of flowCommon StockSEC:0001652410-25-000005:0
16,667 shares@ US$7.397613.7% of flowCommon StockSEC:0001652410-25-000003:0
40,000 shares@ US$5.431140.2% of flowCommon StockSEC:0001867096-25-000047:0
45,909 shares@ US$3.5631.7% of flowCommon StockSEC:0001867096-25-000025:0
32,039 shares@ US$3.6122.7% of flowCommon StockSEC:0001867096-25-000011:0
14,037 shares@ US$2.115.4% of flowCommon StockSEC:0001867096-24-000170:0
750,000 shares0Common StockSEC:0001867096-24-000015:0
15,853 shares0Ordinary SharesSEC:0001209191-23-037406:0
350,000 shares0Common StockSEC:0001867096-23-000020:0
36,798 shares0Ordinary SharesSEC:0001209191-22-039311:0
7,642 shares0Ordinary SharesSEC:0001209191-22-020618:0
225,000 shares0Common StockSEC:0001867096-22-000009:0
26,366 sharesCommon StockSEC:0000899243-21-039248:0
26,366 sharesCommon StockSEC:0000899243-21-039317:0
About Hecht Beth
Hecht Beth is a dirigente linked to Xeris Biopharma Holdings, Inc., Iterum Therapeutics plc and Xeris Pharmaceuticals INC. She has made 19 filings in total, and in the recent filings available, the modal transaction nature is a sale, with EUR 774339 of sales and EUR 0 of purchases between 2021-10-05 and 2026-05-01.